{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:02:34Z","timestamp":1765976554274},"reference-count":12,"publisher":"Hindawi Limited","issue":"8","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1111\/dth.15609","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T07:47:55Z","timestamp":1653896875000},"update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cryptococcal meningitis associated with interleukin\u201017 inhibitor use for psoriasis"],"prefix":"10.1155","volume":"35","author":[{"given":"Joseph","family":"Driver","sequence":"first","affiliation":[{"name":"College of Medicine Texas A&amp;M University  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Zaayman","sequence":"additional","affiliation":[{"name":"Division of Dermatology Baylor Scott &amp; White  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Silfvast\u2010Kaiser","sequence":"additional","affiliation":[{"name":"Department of Dermatology Baylor Scott &amp; White Medical Center \u2013 Temple  Temple Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Menter","sequence":"additional","affiliation":[{"name":"College of Medicine Texas A&amp;M University  Dallas Texas USA"},{"name":"Division of Dermatology Baylor Scott &amp; White  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"issue":"2","key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.cmi.2018.02.002","article-title":"ESCMID study Group for Infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)","volume":"24","author":"Winthrop KL","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01477-13"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15723"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz193"},{"key":"e_1_2_7_6_1","unstructured":"The United States Food and Drug Administration.Siliq (brodalumab) Label. Accessed November 21 2021.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761032lbl.pdf"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017204"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.003"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1716932"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420952423"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.25251\/skin.3.6.2"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13202"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8020054"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.15609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.15609","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.15609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:09Z","timestamp":1671818649000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.15609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1111\/dth.15609"],"URL":"https:\/\/doi.org\/10.1111\/dth.15609","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"2021-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}